Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
Nucleocapsid CoV-2 | 2A7 | Camelid | n/a | single domain-AZdye 568 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
Middle East Respiratory Syndrome Spike 2 (MERS-CoV S2) | polyclonal | Rabbit | n/a | antigen affinity purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
Middle East Respiratory Syndrome Spike 2 (MERS-CoV S2) | polyclonal | Rabbit | n/a | antigen affinity purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
Middle East Respiratory Syndrome Spike 2 (MERS-CoV S2) | monoclonal | Mouse | n/a | Protein A purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV & CoV-2 NP (IgA) | monoclonal | Mouse | n/a | unconjugated | 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV Spike S1 Protein | monoclonal | Mouse | SARS | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
CoV-2/COVID-19 Spike Glycoprotein | polyclonal | Human | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV S glycoprotein | 4G2 | Recombinant Rabbit | SARS Coronavirus | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV S glycoprotein | 4G2 | Recombinant Human | SARS Coronavirus | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV S glycoprotein | 4G2 | Recombinant Human | SARS Coronavirus | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV S glycoprotein | 4G2 | Recombinant Mouse | SARS Coronavirus | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV S glycoprotein | 4G2 | Recombinant Mouse | SARS Coronavirus | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV S glycoprotein | 4G2 | Recombinant Human | SARS Coronavirus | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV S glycoprotein | 4G2 | Recombinant Mouse | SARS Coronavirus | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV & CoV-2 Spike (IgM), clone CR3022 | CR3022 | Mouse | n/a | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
Middle East Respiratory Syndrome Spike (MERS-CoV S) | monoclonal | Mouse | n/a | Protein A purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
Spike of MERS-CoV | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Spike of MERS-CoV | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Nucleocapsid CoV-1/2 | 53E2 | Mouse | n/a | purified | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
Nucleocapsid CoV-1/2 | 53E2 | Mouse | n/a | biotin conjugate | 100 µg | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
Nucleocapsid CoV-1/2 | 2A7 | Camelid | n/a | single domain-Alexa Fluor 647 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
Nucleocapsid CoV-1/2 | 2A7 | Camelid | n/a | single domain-unconjugated | 250 µg | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
Nucleocapsid CoV-1/2 | 2A7 | Camelid | n/a | single domain-DBCO conjugate | 250 µg | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
Nucleocapsid CoV-1/2 | 2A7 | Camelid | n/a | single domain-biotin conjugate | 250 µg | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
MERS-CoV S1 | monoclonal | Recombinant Mouse | MERS-CoV | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
MERS-CoV S1 | monoclonal | Recombinant Mouse | MERS-CoV | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
Middle East Respiratory Syndrome Spike (MERS-CoV S) | polyclonal | Rabbit | n/a | antigen affinity purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
Middle East Respiratory Syndrome Spike (MERS-CoV S) | polyclonal | Rabbit | n/a | antigen affinity purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
Middle East Respiratory Syndrome Spike (MERS-CoV S) | monoclonal | Rabbit | n/a | Protein A purified | 100 µl, 200 µl, 500 µl, | n/a |
ABBEXA LTD |
More Info |
Middle East Respiratory Syndrome Spike (MERS-CoV S) | polyclonal | Rabbit | n/a | Protein A purified | 100 µl, 200 µl, | n/a |
ABBEXA LTD |
More Info |
Middle East Respiratory Syndrome Spike 1 (MERS-CoV S1) | monoclonal | Mouse | n/a | Protein A purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV Spike S1 Subunit Protein | monoclonal | Mouse | SARS | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV Spike S1 Subunit Protein | monoclonal | Mouse | SARS | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Middle East Respiratory Syndrome Spike 1 (MERS-CoV S1) | polyclonal | Rabbit | n/a | antigen affinity purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
Middle East Respiratory Syndrome Spike 1 (MERS-CoV S1) | polyclonal | Rabbit | n/a | antigen affinity purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
Nucleocapsid CoV-2 | CBP17443 | Mouse | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SSARS-CoV-2 COVID-19) S1 Protein | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Etesevimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Nucleocapsid CoV-1/2 | CBP17442 | Mouse | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS N (nucleocapsid) | polyclonal | Mouse | n/a | unconjugated | 50 ug, 100 ug | n/a |
BIORBYT LTD. |
More Info |
S Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | human | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
ORF9b | polyclonal | Rabbit | human | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-1/2 S protein CR3022 | CR3022 | Recombinant Human | SARS virus | unconjugated | n/a | n/a |
MILLIPORE-SIGMA |
More Info |
S Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
Spike of HCoV-NL63 | monoclonal | Rabbit | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Spike of HCoV-NL63 | monoclonal | Rabbit | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
S Protein | P1A7 | Llama | n/a | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
Bamlanivimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Cilgavimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Tixagevimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Spike of HCoV-NL63, HCoV-229E | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Spike of HCoV-NL63, HCoV-229E | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Bamlanivimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Sotrovimab (VIR-7831/GSK4182136) | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
3C-like Proteinase | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
ORF6 | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | monoclonal | Human | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
ORF3a | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
ORF7a | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S2 | RMC7 | Mouse | Coronavirus | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
MERS-CoV Spike (S) protein | [ABM4A80] | Mouse | n/a | Protein G purified | 0.1 mg | n/a |
MYBIOSOURCE INC. |
More Info |
Casirivimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Cilgavimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Imdevimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Sotrovimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Tixagevimab | monoclonal | Recombinant Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
S Protein | DM26 | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | DM27 | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | DM35 | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | DM39 | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | DM40 | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | DM41 | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S1 (MERS-CoV) | polyclonal | Rabbit | n/a | Protein A purified | 0.1 mg | n/a |
MYBIOSOURCE INC. |
More Info |
Spike of HCoV-229E | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Spike of HCoV-229E | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Spike of HCoV-OC43 | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Spike of HCoV-OC43 | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Spike of HCoV-OC43 | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
S Protein | DM24 | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | DM25 | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS virus Sm | polyclonal | Rabbit | n/a | Protein G purified | 80 µl, 400 µl, | n/a |
ABBEXA LTD |
More Info |
S Protein | OTI2D2 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |